Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study

Paola Valenti; Francesco Menicagli; Alfonso Baldi; Gabriele Barella; Chiara Catalucci; Valeria Attorri; Enrico Paolo Spugnini

doi:10.4314/ovj.v11i1.15

2025, Vol: 15, Issue: 3

15 / 3Current Issue Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

OVJ Manuscript Submissio Form

« Previous Article

Original Article

Open Vet J. 2021; 11(1): 100-106

doi: 10.4314/ovj.v11i1.15

Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study

Paola Valenti, Francesco Menicagli, Alfonso Baldi, Gabriele Barella, Chiara Catalucci, Valeria Attorri, Enrico Paolo Spugnini.

Cited By:12

Abstract
Background: Electrochemotherapy (ECT) combines the administration of anticancer drugs with the delivery of electric pulses, thus increasing the drug uptake through the cell membranes, resulting in increased efficacy.
Aim: The aim of our study was to describe the tolerability and efficacy of ECT for the treatment of Apocrine Gland Anal Sac Adenocarcinoma (AGASAC).
Methods: Medical records of dogs with a diagnosis of AGASAC that were treated with ECT were retrospectively evaluated.
Each dog received 20 mg/m2 of bleomycin intravenously. Based on clinician decision, the primary tumor or tumor bed was also infiltrated with cisplatin at the dose of 0.5 mg/cm2.
Trains of permeabilizing biphasic electric pulses were then applied under general anesthesia.
Results: Ten dogs were enrolled in the study.
Six dogs (60 %) had partial response (PR), 3 dogs (30 %) had stable disease (SD) and one dog treated for microscopic disease did not show any sign of local relapse 305 days after treatment, being still alive and in complete remission (CR) at the time of writing.
Median time to progression was 303 days and median survival time was 365 days.
The treatment was well tolerated and local side effects were minimal. No systemic effects were documented.
Conclusion: This preliminary study suggests that ECT may be beneficial for dogs with AGASAC and could be a useful addition to the current therapeutic options in consideration of its low cost, limited toxicity and ease of administration.

Key words: Anal Gland Anal Sac Adenocarcinoma, Bleomycin, Cisplatin, Dog, Electrochemotherapy

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	HTML Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Paola Valenti Articles by Francesco Menicagli Articles by Alfonso Baldi Articles by Gabriele Barella Articles by Chiara Catalucci Articles by Valeria Attorri Articles by Enrico Paolo Spugnini
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Valenti P, Menicagli F, Baldi A, Barella G, Catalucci C, Attorri V, Spugnini EP. Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. Open Vet J. 2021; 11(1): 100-106. doi:10.4314/ovj.v11i1.15

Web Style

Valenti P, Menicagli F, Baldi A, Barella G, Catalucci C, Attorri V, Spugnini EP. Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. https://www.openveterinaryjournal.com/?mno=109 [Access: April 06, 2025]. doi:10.4314/ovj.v11i1.15

AMA (American Medical Association) Style

Valenti P, Menicagli F, Baldi A, Barella G, Catalucci C, Attorri V, Spugnini EP. Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. Open Vet J. 2021; 11(1): 100-106. doi:10.4314/ovj.v11i1.15

Vancouver/ICMJE Style

Valenti P, Menicagli F, Baldi A, Barella G, Catalucci C, Attorri V, Spugnini EP. Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. Open Vet J. (2021), [cited April 06, 2025]; 11(1): 100-106. doi:10.4314/ovj.v11i1.15

Harvard Style

Valenti, P., Menicagli, . F., Baldi, . A., Barella, . G., Catalucci, . C., Attorri, . V. & Spugnini, . E. P. (2021) Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. Open Vet J, 11 (1), 100-106. doi:10.4314/ovj.v11i1.15

Turabian Style

Valenti, Paola, Francesco Menicagli, Alfonso Baldi, Gabriele Barella, Chiara Catalucci, Valeria Attorri, and Enrico Paolo Spugnini. 2021. Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study. Open Veterinary Journal, 11 (1), 100-106. doi:10.4314/ovj.v11i1.15

Chicago Style

Valenti, Paola, Francesco Menicagli, Alfonso Baldi, Gabriele Barella, Chiara Catalucci, Valeria Attorri, and Enrico Paolo Spugnini. "Evaluation of electrochemotherapy in the management of anal sac apocrine gland adenocarcinomas in dogs: a retrospective study." Open Veterinary Journal 11 (2021), 100-106. doi:10.4314/ovj.v11i1.15

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Author Login Reviewer Login About Publisher Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Terms of Use License Information Copyright Information

About Open Veterinary Journal

Open Veterinary Journal provides a fast track coupled with high quality peer review process for original research articles, review articles, short communi ... Read more.

For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes: Owner, Founder and Editor-in-Chief

Open Veterinary Journal

Faculty of Veterinary Medicine, University of Tripoli

P.O. Box 13662, Tripoli, Libya

and

Eldaghayes Publisher

www.eldagpublisher.com

Email: ibrahim.eldaghayes@vetmed.edu.ly

About Open Veterinary Journal

Contact Information

How to cite this article